Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

An astrophysics pioneer at Kovsies
2014-01-05

Prof Pieter Meintjes

Over the last decade Prof Pieter Meintjes’ strong background in astrophysics led to the development of a course of excellence at the University of the Free State.

Today we present an Astrophysics degree at our university, from first-year courses to PhDs.

Meintjes matriculated at the Sybrand van Niekerk High School in Sabie and completed a BSc in Physics and Mathematics at the North-West University in 1988. In 1990 and 1993 he respectively obtained his MSc and PhD in Physics from the same university.

Hereafter he spent a post-doctoral year at the Max Planck Institute for Space Science near München in Germany. In January 1997, Meintjes was appointed as a senior lecturer at our university’s Department of Physics. He was promoted to Professor in Physics in 2008.

Prof Meintjes is a member of the South African Institute for Physics (SAIP) and during 2002-2004 he was also co-chair of the astrophysics and space science group of SAIP. He serves on the executive committee of the National Astrophysics and Space Science Programme (NASSP) and is often a visiting lecturer at the University of Cape Town. He is a NRF-supported researcher and author and co-author of 70 publications in high-profile international journals and published conference issues.

During 2011-2013 he successfully delivered three PhD students along with one MSc student. His PhD students also delivered addresses at international conferences in Champery (Switzerland), Heidelberg (Germany), Paris (France), Barcelona (Spain) and Milan (Italy), Cape Town and the Kruger Game Reserve.

Over the last two years he has also been the author and co-author of six publications in Monthly Notices of the Royal Astronomical Society (MNRAS), as well as various publications in the Astrophysical Journal in support of the international planet search programme. A further 12 publications also came forth from Meintjes’ international conference contributions.

During the recent H.E.S.S. meeting in Namibia, Meintjes was appointed as the latest member of the highly-regarded international cooperation with H.E.S.S.

His membership of the H.E.S.S. group is due to his knowledge on gamma rays, which entails research on high-energy astrophysics.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept